First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · IEX Real-Time Price · USD
26.97
-0.30 (-1.08%)
Jul 2, 2024, 4:00 PM EDT - Market closed
FTXH Holdings List
As of Jun 27, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | PFE | Pfizer Inc. | 7.54% |
2 | MRK | Merck & Co., Inc. | 7.36% |
3 | ABBV | AbbVie Inc. | 6.92% |
4 | JNJ | Johnson & Johnson | 6.51% |
5 | BMY | Bristol-Myers Squibb Company | 5.89% |
6 | UTHR | United Therapeutics Corporation | 4.59% |
7 | LLY | Eli Lilly and Company | 4.35% |
8 | AMGN | Amgen Inc. | 4.13% |
9 | VRTX | Vertex Pharmaceuticals Incorporated | 4.04% |
10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.92% |
11 | BIIB | Biogen Inc. | 3.80% |
12 | GILD | Gilead Sciences, Inc. | 3.44% |
13 | ZTS | Zoetis Inc. | 3.20% |
14 | CAH | Cardinal Health, Inc. | 3.20% |
15 | VTRS | Viatris Inc. | 3.05% |
16 | OGN | Organon & Co. | 2.94% |
17 | JAZZ | Jazz Pharmaceuticals plc | 2.85% |
18 | CRL | Charles River Laboratories International, Inc. | 1.75% |
19 | HALO | Halozyme Therapeutics, Inc. | 1.61% |
20 | MEDP | Medpace Holdings, Inc. | 1.54% |
21 | PRGO | Perrigo Company plc | 1.17% |
22 | INCY | Incyte Corporation | 1.06% |
23 | ALKS | Alkermes plc | 0.91% |
24 | EXEL | Exelixis, Inc. | 0.88% |
25 | NBIX | Neurocrine Biosciences, Inc. | 0.84% |
26 | PBH | Prestige Consumer Healthcare Inc. | 0.79% |
27 | ELAN | Elanco Animal Health Incorporated | 0.71% |
28 | MRUS | Merus N.V. | 0.62% |
29 | SRPT | Sarepta Therapeutics, Inc. | 0.62% |
30 | BPMC | Blueprint Medicines Corporation | 0.58% |
31 | KRYS | Krystal Biotech, Inc. | 0.58% |
32 | n/a | Dreyfus Govt Cm Inst 289 | 0.57% |
33 | IONS | Ionis Pharmaceuticals, Inc. | 0.53% |
34 | TGTX | TG Therapeutics, Inc. | 0.52% |
35 | ITCI | Intra-Cellular Therapies, Inc. | 0.51% |
36 | ILMN | Illumina, Inc. | 0.51% |
37 | ACLX | Arcellx, Inc. | 0.50% |
38 | BMRN | BioMarin Pharmaceutical Inc. | 0.49% |
39 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.47% |
40 | ROIV | Roivant Sciences Ltd. | 0.46% |
41 | NUVL | Nuvalent, Inc. | 0.46% |
42 | MLTX | MoonLake Immunotherapeutics | 0.43% |
43 | RARE | Ultragenyx Pharmaceutical Inc. | 0.40% |
44 | EXAS | Exact Sciences Corporation | 0.39% |
45 | IDYA | IDEAYA Biosciences, Inc. | 0.39% |
46 | KYMR | Kymera Therapeutics, Inc. | 0.36% |
47 | ACAD | ACADIA Pharmaceuticals Inc. | 0.35% |
48 | VKTX | Viking Therapeutics, Inc. | 0.33% |
49 | CRSP | CRISPR Therapeutics AG | 0.33% |
50 | BEAM | Beam Therapeutics Inc. | 0.31% |
As of Jun 27, 2024